| Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (NCT01999868) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-19 |
| Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome (NCT02101138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-14 |
| Safety of Sublingual dmLT for ETEC (NCT02052934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-10 |
| Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda (NCT02094508) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-07 |
| Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor (NCT02069080) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-02-20 |
| Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy (NCT01976715) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-02-11 |
| Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 (NCT02064933) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-02-02 |
| Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness (NCT02057757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-02-01 |
| Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age (NCT02186626) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-02-01 |
| Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications (NCT01949116) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-31 |
| Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection (NCT01780831) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-28 |
| Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models (NCT02015013) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-15 |
| BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (NCT02029638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-07 |
| A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects (NCT02037282) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-03 |
| T and B Cell Responses in Autoimmune Diseases (NCT01947036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-01 |
| Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults (NCT02015091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-12 |
| The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study (NCT01949363) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-01 |
| Defining Immune Tolerance in ANCA-associated Vasculitis (AAV) (NCT01934504) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-01 |
| Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) (NCT02008578) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-01 |
| Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) (NCT01946880) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-20 |
| Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers (NCT01989533) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-19 |
| Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults (NCT01993706) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-19 |
| Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults (NCT02021968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-01 |
| Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis (NCT01953354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-01 |
| Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults (NCT01988636) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-29 |
| Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children (NCT01968083) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-03 |
| Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children (NCT01852266) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-01 |
| A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study (NCT01974999) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-01 |
| Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults (NCT01995695) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-01 |
| Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection (NCT01915212) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-26 |
| H7N9 Mix and Match With MF59 in Healthy Adults (NCT01938742) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| Peanut Epicutaneous Phase II Immunotherapy Clinical Trial (NCT01904604) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People (NCT01971255) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| H7N9 Mix and Match With AS03 and MF59 in Healthy Adults (NCT01942265) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria (NCT01955382) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| Natural History Study of GATA2 Deficiency and Related Disorders (NCT01905826) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-26 |
| VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected... (NCT01950325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-22 |
| Peanut Oral Immunotherapy in Children (NCT01867671) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-13 |
| Aerosolized and Intravenous Colistin in Healthy Adults (NCT01863719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-06 |
| Study of the Complications Associated With Certain Stem Cell Transplants (NCT01919099) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-07-31 |
| Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women (NCT01915251) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-07-30 |
| Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen (NCT01856257) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-07-01 |
| Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) (NCT01910519) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-07-01 |
| Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children (NCT01893554) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation (NCT01769443) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults (NCT01931176) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus (NCT01709474) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE® (NCT01827371) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV (NCT01878799) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Therapeutic Vaccine for HIV (NCT01859325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-05-10 |
| Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease (NCT01851460) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-05-08 |
| 11C-5-HTP PET in Clinical Islet Transplantation (NCT02689479) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-05-01 |
| Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463 (NCT01812889) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-04-01 |
| Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults (NCT01783977) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-04-01 |
| Human Rhinovirus Infection and Airway Remodeling Mediators (NCT01847768) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-04-01 |
| Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine (NCT01867463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-27 |
| Malaria Transmission Studies in Mali (NCT01829737) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-20 |
| Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children (NCT01504841) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-14 |
| Idebenone for Primary Progressive Multiple Sclerosis (NCT01854359) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-12 |
| Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial) (NCT04870138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-10 |
| Sirolimus for Eosinophil-Associated Gastrointestinal Disorders (NCT01814059) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-07 |
| Intranasal AD4-H5-VTN as an Adenovirus Vaccine (NCT01806909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-06 |
| Validation of Gene Expression Markers of Renal Allograft Functional Decline (NCT01782586) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-01 |
| LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine (NCT01751048) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-01 |
| Collection of Biological Material From Pregnant Women in a Malarial Region (NCT01862783) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-02-10 |
| Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation (NCT01790594) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-02-01 |
| Bone Marrow Stromal Cells for Inflammatory Bowel Diseases (NCT01851343) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-27 |
| Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3 (NCT01336699) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-07 |
| Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations (NCT01746082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Effect of Filarial Infection on Immune Responses in Latent Tuberculosis (NCT01547884) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Combination Therapy for Chronic Hepatitis C Infection (NCT01805882) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Sildenafil for PNTM Infection (NCT01853540) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart (NCT01782300) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Testing the AVI-7100 Flu Drug in Healthy Volunteers (NCT01747148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-12-08 |
| Phase 2a EBA Trial of AZD5847 (NCT01516203) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-12-05 |
| Volunteer Screening for Vaccine and Antivirals Clinical Trials (NCT01593709) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-11-27 |
| Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults (NCT01730144) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-11-17 |
| Natural History of Individuals With Immune System Problems That Lead to Fungal Infections (NCT01386437) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-11-05 |
| CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") (NCT01552369) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-29 |
| Tdap Vaccine in Post-Partum Women (NCT01711645) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-26 |
| A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (NCT01654263) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-10 |
| Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study (NCT01737710) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-01 |
| Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics (NCT01632995) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-01 |
| Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) (NCT01306019) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-09-25 |
| Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines (NCT01674205) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-09-01 |
| Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers (NCT01674218) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-09-01 |
| Clinical Outcomes of People Who Acquired HIV in Early Life (NCT01656564) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-27 |
| Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients (NCT01638559) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-14 |
| Fluorodeoxyglucose Imaging Studies to Detect Lymphoma (NCT01672918) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-06 |
| Genomics of Kidney Transplantation (NCT01714440) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-01 |
| Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years (NCT01676402) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-01 |
| Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73 (NCT01592214) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-01 |
| Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients (NCT01672164) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-01 |
| Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome (NCT01552681) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-07-01 |
| Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule (NCT01641991) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-07-01 |
| Artemisinin-resistant Malaria in Cambodia (NCT01736319) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-26 |
| Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women (NCT01505114) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults (NCT01574638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents (NCT01609998) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| Gene Expression in HIV and Tuberculosis Co-infection (NCT01611402) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-29 |